Patent · US Active

Pharmaceutical compositions comprising nebivolol

US11576893B2 · kind B2 · utility

4Cited by

68References

21Claims

0Family size

Assignee

NOVALIQ GMBH · DE

Inventors

Frank LÖSCHER · Schriesheim, DE
Kirsten EICKHOFF · Aschaffenburg, DE
Diana STREHL · Heidelberg, DE

Key dates

Filing date	Mar 1, 2019
Grant date	Feb 14, 2023
Priority date	—
Expiry date	Mar 1, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical compositions comprising the selective beta 1 (B1)-receptor blocker nebivolol and/or a pharmaceutically acceptable salt thereof and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention is useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.